STATE OF WISCONSIN INVESTMENT BOARD - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,273,404
-27.5%
41,506
-5.3%
0.00%
-20.0%
Q2 2023$1,755,627
-25.3%
43,814
-23.9%
0.01%
-28.6%
Q1 2023$2,349,228
+32.2%
57,565
+25.1%
0.01%
+16.7%
Q4 2022$1,776,601
-26.5%
46,014
+1.2%
0.01%
-25.0%
Q3 2022$2,418,000
-14.0%
45,469
-5.7%
0.01%
+14.3%
Q2 2022$2,811,000
-37.6%
48,211
-18.3%
0.01%
-22.2%
Q1 2022$4,503,000
+26.8%
59,0000.0%0.01%
+28.6%
Q4 2021$3,550,000
+7.4%
59,0000.0%0.01%0.0%
Q3 2021$3,304,000
-7.7%
59,0000.0%0.01%0.0%
Q2 2021$3,580,000
-13.4%
59,0000.0%0.01%
-22.2%
Q1 2021$4,135,000
+17.1%
59,0000.0%0.01%
+12.5%
Q4 2020$3,531,000
-11.4%
59,000
-11.0%
0.01%
-20.0%
Q3 2020$3,986,000
+14.6%
66,3000.0%0.01%0.0%
Q2 2020$3,479,000
+63.9%
66,300
+4.7%
0.01%
+42.9%
Q1 2020$2,122,000
-23.1%
63,300
+3.9%
0.01%0.0%
Q4 2019$2,759,000
+19.0%
60,9000.0%0.01%
+16.7%
Q3 2019$2,318,000
-7.9%
60,900
+5.2%
0.01%
-14.3%
Q2 2019$2,518,000
+25.1%
57,900
+9.5%
0.01%
+16.7%
Q1 2019$2,013,000
+14.7%
52,900
+29.7%
0.01%0.0%
Q4 2018$1,755,000
-12.0%
40,800
+0.5%
0.01%0.0%
Q3 2018$1,995,000
+53.3%
40,6000.0%0.01%
+50.0%
Q2 2018$1,301,000
+6.0%
40,600
+3.0%
0.00%0.0%
Q1 2018$1,227,000
-31.8%
39,4000.0%0.00%
-20.0%
Q4 2017$1,799,000
+65.2%
39,400
+35.9%
0.01%
+66.7%
Q3 2017$1,089,000
-21.3%
29,0000.0%0.00%
-25.0%
Q2 2017$1,383,00029,0000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders